Precision Epigenomics Inc filed a Form D with the Securities and Exchange Commission on 2025-09-23.
Precision Epigenomics Inc filed a Form D notice of an exempt securities offering with the SEC on September 23, 2025. The filing reports $265K sold. Its industry group is Biotechnology. It names Mark Nelson (Executive Officer, Director), Lisa Shaffer (Director), Richard Bernert (Executive Officer, Director) (SEC Form D, September 23, 2025).
Is this your company?
Sell to companies like Precision Epigenomics Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-09-23 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Precision Epigenomics Inc.
Free to see. No signup.
More on the people and the money behind Precision Epigenomics Inc, from the filings we hold.
Biotechnology raises filed within 90 days of this one, largest first.
Get an email when Precision Epigenomics Inc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Precision Epigenomics Inc raises, hires or launches. No email unless you switch it on.
Watch Precision Epigenomics Inc →Get the full cited report on Precision Epigenomics Inc
What the filing shows about Precision Epigenomics Inc
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Precision Epigenomics Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Precision Epigenomics Inc's address as 630 N. Alvernon Way, Suite 280B, Tucson, AZ 85711.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Precision Epigenomics Inc See pricing
Precision Epigenomics Inc is a registered filer with the SEC (CIK 2017642) and has filed since 2024-04-01. 2 filings are on record, the latest on 2025-09-23.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Precision Epigenomics Inc's Form D of 2025-09-23 names Mark Nelson, Lisa Shaffer, Richard Bernert and 4 more as its officers, directors or promoters.
Its new offerings report $1.38M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Mark Nelson is named as Executive Officer and Director on the Form D that Precision Epigenomics Inc filed with the SEC on 23 September 2025, one of 7 people that filing names.
Lisa Shaffer is named as Director on the Form D that Precision Epigenomics Inc filed with the SEC on 23 September 2025, one of 7 people that filing names.
Richard Bernert is named as Executive Officer and Director on the Form D that Precision Epigenomics Inc filed with the SEC on 23 September 2025, one of 7 people that filing names.
Marie Wesselhoft is named as Director on the Form D that Precision Epigenomics Inc filed with the SEC on 23 September 2025, one of 7 people that filing names.
Matthew Miller is named as Executive Officer on the Form D that Precision Epigenomics Inc filed with the SEC on 23 September 2025, one of 7 people that filing names.
Barnard Futscher is named as Executive Officer on the Form D that Precision Epigenomics Inc filed with the SEC on 23 September 2025, one of 7 people that filing names.
Lisa Jensen-Long is named as Executive Officer on the Form D that Precision Epigenomics Inc filed with the SEC on 23 September 2025, one of 7 people that filing names.
7 people named on the filing — 5 holding an executive role and 2 as directors only.
Named as of the 2025-09-23 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Precision Epigenomics Inc
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Precision Epigenomics Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Precision Epigenomics Inc covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Precision Epigenomics IncYou get an alert in MentionFox the next time this company shows up.
If you're behind Precision Epigenomics Inc: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Precision Epigenomics Inc. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/precision-epigenomics-inc-form-d-25000001